These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 8858461

  • 1. Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether.
    Prada J, Müller S, Bienzle U, Kremsner PG.
    J Antimicrob Chemother; 1996 Jul; 38(1):95-102. PubMed ID: 8858461
    [Abstract] [Full Text] [Related]

  • 2. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
    Gumede B, Folb P, Ryffel B.
    Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
    [Abstract] [Full Text] [Related]

  • 3. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
    Orjuela-Sánchez P, Ong PK, Zanini GM, Melchior B, Martins YC, Meays D, Frangos JA, Carvalho LJ.
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria.
    Kwiatkowski D, Bate C.
    Trans R Soc Trop Med Hyg; 1995 Nov; 89(2):215-6. PubMed ID: 7778153
    [No Abstract] [Full Text] [Related]

  • 5. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N, Torre S, Gauthier S, Tam M, Hawari J, Vandercruyssen K, De Spiegeleer B, Fortin A, Stevenson MM, Gros P.
    Malar J; 2016 May 06; 15(1):260. PubMed ID: 27150250
    [Abstract] [Full Text] [Related]

  • 6. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
    Yalcin O, Oronsky B, Carvalho LJ, Kuypers FA, Scicinski J, Cabrales P.
    Malar J; 2015 May 28; 14():218. PubMed ID: 26017006
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo.
    Chimanuka B, François G, Timperman G, Heyden YV, Holenz J, Plaizier-Vercammen J, Bringmann G.
    Parasitol Res; 2001 Oct 28; 87(10):795-803. PubMed ID: 11688884
    [Abstract] [Full Text] [Related]

  • 8. [Additive therapeutic effect of a combination of artemether and daphnetin against Plasmodium berghei in mice].
    Guo J, Ni YC, Wu JT, Wang QM.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun 28; 22(3):164-6. PubMed ID: 15597713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
    Peters W, Li ZL, Robinson BL, Warhurst DC.
    Ann Trop Med Parasitol; 1986 Oct 28; 80(5):483-9. PubMed ID: 3307655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
    Reis PA, Comim CM, Hermani F, Silva B, Barichello T, Portella AC, Gomes FC, Sab IM, Frutuoso VS, Oliveira MF, Bozza PT, Bozza FA, Dal-Pizzol F, Zimmerman GA, Quevedo J, Castro-Faria-Neto HC.
    PLoS Pathog; 2010 Jun 24; 6(6):e1000963. PubMed ID: 20585569
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
    Dai M, Freeman B, Bruno FP, Shikani HJ, Tanowitz HB, Weiss LM, Reznik SE, Stephani RA, Desruisseaux MS.
    Life Sci; 2012 Oct 15; 91(13-14):687-92. PubMed ID: 22820174
    [Abstract] [Full Text] [Related]

  • 17. NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.
    Bertinaria M, Orjuela-Sanchez P, Marini E, Guglielmo S, Hofer A, Martins YC, Zanini GM, Frangos JA, Gasco A, Fruttero R, Carvalho LJ.
    J Med Chem; 2015 Oct 08; 58(19):7895-9. PubMed ID: 26367273
    [Abstract] [Full Text] [Related]

  • 18. Schizontocidal effects of oral artesunate on Plasmodium berghei in mice and P knowlesi in monkeys.
    Shi YL, Li GF, Zhao JH, Yang JD, Ding DB.
    Zhongguo Yao Li Xue Bao; 1999 Aug 08; 20(8):755-8. PubMed ID: 10678113
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of the schizontocidal efficacy and safety of artemether versus chloroquine in uncomplicated malaria.
    Simooya O, Mutetwa S, Chandiwana S, Neill P, Mharakurwa S, Stein M.
    Cent Afr J Med; 1992 Jul 08; 38(7):257-63. PubMed ID: 1477874
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.